semaglutide heart failure trial in Patients with Obesity-Related and Type 2 Diabetes π« ESC '23 Highlights πAmsterdam
Description
Risks and benefits of GLP-1 pills vs
(The Gold Standard for Appetite Control) Semaglutide is the active ingredient found in well-known brands like Ozempic and Wegovy
5.9% of participants stopped use due to side effects In one study, 5.9% of trial participants in the semaglutide study had to discontinue use due to side effects
This established the dual agonist mechanisms utility beyond weight loss and is relevant context for the broader mechanistic comparison in metabolic disease research
Any switch is a decision for you and your doctor
Data on graph cut off at the 5th and 95th percentile of whole dataset
